![DIERGOSPRAY 4 mg/ml, solution pour pulvérisation nasale : Notice, Posologie, Indication - PasseportSanté DIERGOSPRAY 4 mg/ml, solution pour pulvérisation nasale : Notice, Posologie, Indication - PasseportSanté](http://prod-bdm.ansm.integra.fr/Rcp_Notices/images//N0341941/image001.png)
DIERGOSPRAY 4 mg/ml, solution pour pulvérisation nasale : Notice, Posologie, Indication - PasseportSanté
![FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | Nation & World News | komu.com FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | Nation & World News | komu.com](https://bloximages.newyork1.vip.townnews.com/komu.com/content/tncms/assets/v3/editorial/a/49/a49c7aab-9dda-57f6-a869-cdd9c60054b5/640b72262e9cf.image.jpg?crop=1918%2C1079%2C0%2C0&resize=1918%2C1079&order=crop%2Cresize)
FDA approves new nasal spray to treat migraine headaches in adults, Pfizer says | Nation & World News | komu.com
Rôle du pharmacien d'officine dans la prise en charge de la migraine et des céphalées chroniques quotidiennes par abus méd
Recommandations Sur La Prise en Charge Diagnostique Et Thérapeutique de La Migraine Chez L'adulte Et Chez L'enfant | PDF | Migraine | Céphalée
![Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial - The Lancet Neurology Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/050c10c7-d011-491d-ae0d-159b4f59a1cf/gr1_lrg.jpg)